StockWatch
·
PRECISION CAMSHAFTS LTD · QQ1 FY-2027 · THE CALL

Pipeline is strong; Q1 results and EMOSS drag weaken the signal

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsPRECAMPrecision Camshafts Ltd31 Aug 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B-

Order book reaffirmed (₹1,500 Cr); no new guidance. YoY results materially miss. Capex/margin targets withheld.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Order book and new program ramps support medium-term growth trajectory, but Q1's 55% YoY PAT decline and EMOSS revenue collapse are material near-term headwinds. Management's 'strong performance' framing obscures consolidated weakness; no FY27 guidance provided.

₹187.9 Cr

Revenue · −3.6% YoY

₹8.4 Cr

Reported PAT · −55.1% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Delivered strong performance in Q1 FY27

OVERSTATED

Consolidated revenue -3.6% YoY (₹187.9 Cr), PAT -55.1% YoY (₹8.4 Cr); PAT margin compressed to 4.2%

New programs with Mahindra, Tata Motors, Maruti Suzuki started production

MET

Call explicitly states these three major OEMs' programs began in Q1; volumes expected to ramp progressively

Cumulative order book of ₹1,500 Cr

MET

Confirmed ₹1,500 Cr over 4–5 years; management disclosed this already in prior con-calls and AGM, not incremental

Considerable confidence in medium and long-term growth

MET

Order book provides ~₹300–375 Cr annual incremental revenue; depends on execution and customer ramp timelines. Real but not explosive.

EMOSS slowdown due to EV market headwinds

MET

EMOSS revenue halved QoQ (₹29 Cr → ₹13.8 Cr). EV truck adoption in EU only 4.8%; subsidy pullback cited. Material drag on consolidated results.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Order book reaffirmed

Neutral

₹1,500 Cr remains unchanged; management confirmed it is already disclosed, not new. No incremental order wins quantified.

EMOSS caution deepened

Downgrade

Revenue halved QoQ (₹29 → ₹13.8 Cr). Management said market 'challenging,' considering wind-up option, taking 'cautious view.' Previously guided a ramp; now protective.

India business confidence raised

Upgrade

Three major OEM programs launched in Q1 vs none prior call. Management 'extremely confident' in India long-term. New orders secured but not quantified.

No FY27 numeric guidance

Withdrawn

Prior calls implied ₹120 Cr capex, growth from new orders. This call provides no FY27 revenue, PAT, or capex target.

The Q&A

Light Q&A. Navneet Kamalia (investor) pressed on order book transparency (answered), EMOSS wind-up risk (deflected as 'hard to say'), and presentation quality (acknowledged). Management held tone but hedged on EMOSS. No analyst scrutiny on margins or capex.

The exchanges that mattered

Business scope — Nishit Sanghvi, Neo Mill

Answered

Multiple opportunities; focus on India standalone and MEMCO new products; actively exploring acquisitions for India growth in new products/customers.

Order book disclosure — Navneet Kamalia, Individual Investor

Answered

₹1,500 crores cumulative from existing and new customers, spread over 4–5 years. Already disclosed in prior calls and AGM. Still working on newer opportunities.

EMOSS wind-up risk — Navneet Kamalia, Individual Investor

Partial

Markets are dynamic; unprecedented situations in Europe last 8–9 months. Tremendous headwinds but trying to sustain as standalone. Hard to answer right now.

Presentation quality — Navneet Kamalia, Individual Investor

Answered

Will take feedback back and see what additional information can be added next quarter.

Guidance

Forward guidance and management's confidence

No FY27 revenue target provided

N/A

Management cites ₹1,500 Cr order book over 4–5 years (₹300–375 Cr/year incremental) but no FY27 total revenue or YoY growth % stated.

No FY27 margin target provided

N/A

Standalone Q1 PAT margin 9%; consolidated 4.2%. No guidance on FY27 target or EMOSS contribution assumption.

Capex amount not specified; investing in capacity, automation, technology

Low

Prior call cited ₹120 Cr for FY26–27. This call only qualitative; no FY27 capex target or timeline given.

Risks the call surfaced

Ranked by how much they should concern a holder

EMOSS deterioration

High

EMOSS revenue halved QoQ (₹29 → ₹13.8 Cr). EV truck adoption only 4.8% in EU; subsidy pullback ongoing. Margin low/negative; could require wind-up or capital support.

PAT margin compression

Medium

Consolidated PAT margin 4.2% vs standalone 9%. EMOSS drag is acute. If new programs (Mahindra, Tata, Maruti) achieve lower-than-historical margins, consolidated recovery could be delayed.

Order book execution

Medium

₹1,500 Cr order book spread over 4–5 years depends on customer capex cycles and production scaling. Ramp timelines could slip if OEM investment or demand softens.

Customer concentration

Medium

Only 3–4 OEMs explicitly named (Mahindra, Tata, Maruti, Bosch). No disclosure of top-customer % or revenue mix by customer. Concentration risk not quantified.

Macro headwinds

Medium

Call cites 'disruptions due to Middle East war.' Indian PV growth momentum assumed but unverified in call. EU subsidy pullback continues to drag EMOSS.

Management

Score 6/10. Clear on India strategy and order book; hedged on EMOSS future. Presented Q1 as 'strong' despite 55% YoY PAT decline; framing misleading. Declined to quantify FY27 guidance. Delivered on order book disclosure and program launches (Mahindra, Tata, Maruti). Capex target from prior call (₹120 Cr) not reiterated. EMOSS deterioration unplanned.

What to watch next
  • 1 · Q2–Q3 FY27

    New program volume ramps (Mahindra, Tata, Maruti). Critical for revenue re-acceleration.

  • 2 · H2 FY27

    Additional program launches from pipeline. Could add incremental revenue if customers' capex cycles hold.

  • 3 · FY27 full year

    EMOSS stabilization or wind-up decision. Will clarify drag on consolidated PAT margins.

Management's 'strong performance' framing obscures consolidated weakness; no FY27 guidance provided.

Informational and educational content only. Not investment advice.